Login / Signup
Purushotham Guroji
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Drug Resistant
Cell Death
Cardiovascular Events
Big Data
Top Venues
Molecular carcinogenesis
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ritesh K Srivastava
,
Purushotham Guroji
,
Lin Jin
,
M Shahid Mukhtar
,
Mohammad Athar
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
Molecular carcinogenesis
61 (8) (2022)